Microbiomics faces challenges with regard to standardization and harmonization. In this special edition newsletter, learn about improving microbiome measurement accuracy and reproducibility across labs, optimizing sample collection for microbiome analysis and more!
In modern hereditary disease testing, valuable information can be missed due to inadequate mining and interpretation. These "knowledge blind spots" can have significant clinical consequences. The Human Gene Mutation Database is the gold standard resource for coverage of published germ-line human inherited disease mutations. Learn more with this white paper!
Today Lonza announced the latest addition to its cell-culture product portfolio – the Quasi Vivo® System. The Quasi Vivo® Device consists of an advanced, interconnected fluidics system to create more physiologically relevant cell-culture conditions, helping researchers improve the predictive value of their studies.
Advanced Instruments, the world’s leading authority in osmometry, announces the newest member of the Advanced™ family of freezing point osmometers. Osmo1 is ideally suited for clinical laboratories who prefer to directly draw and test small sample volumes.
Analyzing a large protein using a traditional Western blot can be very complicated. The gel can break, the transfer can take forever, and reproducibility can be challenging. Find out how capillary-based protein separation techniques can help with this application note!
During the Society of Toxicology Meeting from 11-15 March 2018 at the Henry B. González Convention Center in San Antonio, TX (USA), Lonza will present two posters highlighting its latest research into developing more physiologically relevant in vitro cell-culture models for ADME-Tox testing.